Skip to main content
Top
Published in: World Journal of Surgical Oncology 1/2013

Open Access 01-12-2013 | Research

Investigating citrullinated proteins in tumour cell lines

Authors: Zhongmin Jiang, Yazhou Cui, Lin Wang, Yan Zhao, Suhua Yan, Xiaotian Chang

Published in: World Journal of Surgical Oncology | Issue 1/2013

Login to get access

Abstract

Background

The conversion of arginine into citrulline, termed citrullination, has important consequences for the structure and function of proteins. Studies have found PADI4, an enzyme performing citrullination, to be highly expressed in a variety of malignant tumours and have shown that PADI4 participates in the process of tumorigenesis. However, as citrullinated proteins have not been systematically investigated in tumours, the present study aimed to identify novel citrullinated proteins in tumours by 2-D western blotting (2-D WB).

Methods

Two identical two-dimensional electrophoresis (2-DE) gels were prepared using extracts from ECA, H292, HeLa, HEPG2, Lovo, MCF-7, PANC-1, SGC, and SKOV3 tumour cell lines. The expression profiles on a 2-DE gel were trans-blotted to PVDF membranes, and the blots were then probed with an anti-citrulline antibody. By comparing the 2-DE profile with the parallel 2-D WB profile at a global level, protein spots with immuno-signals were collected from the second 2-DE gel and identified using mass spectrometry. Immunoprecipitation was used to verify the expression and citrullination of the targeted proteins in tumour cell lines.

Results

2-D WB and mass spectrometry identified citrullinated α-enolase (ENO1), heat shock protein 60 (HSP60), keratin 8 (KRT8), tubulin beta (TUBB), T cell receptor chain and vimentin in these cell lines. Immunoprecipitation analyses verified the expression and citrullination of ENO1, HSP60, KRT8, and TUBB in the total protein lysates of the tumour cell lines.

Conclusions

The citrullination of these proteins suggests a new mechanism in the tumorigenic process.
Appendix
Available only for authorised users
Literature
1.
go back to reference György B, Tóth E, Tarcsa E, Falus A, Buzás EI: Citrullination: a posttranslational modification in health and disease. Int J Biochem Cell Biol. 2006, 38: 1662-1677. 10.1016/j.biocel.2006.03.008.CrossRefPubMed György B, Tóth E, Tarcsa E, Falus A, Buzás EI: Citrullination: a posttranslational modification in health and disease. Int J Biochem Cell Biol. 2006, 38: 1662-1677. 10.1016/j.biocel.2006.03.008.CrossRefPubMed
2.
go back to reference Takahara H, Okamoto H, Sugawara K: Specific modification of the functional arginine residue in soybean trypsin inhibitor (Kunitz) by peptidylarginine deiminase. J Biol Chem. 1985, 260: 8378-8383.PubMed Takahara H, Okamoto H, Sugawara K: Specific modification of the functional arginine residue in soybean trypsin inhibitor (Kunitz) by peptidylarginine deiminase. J Biol Chem. 1985, 260: 8378-8383.PubMed
3.
go back to reference Kubilus J, Waitkus RF, Baden HP: Partial purification and specificity of an arginine-converting enzyme from bovine epidermis. Biochim Biophys Acta. 1980, 615: 246-251. 10.1016/0005-2744(80)90027-3.CrossRefPubMed Kubilus J, Waitkus RF, Baden HP: Partial purification and specificity of an arginine-converting enzyme from bovine epidermis. Biochim Biophys Acta. 1980, 615: 246-251. 10.1016/0005-2744(80)90027-3.CrossRefPubMed
4.
go back to reference Inagaki M, Takahara H, Nishi Y, Sugawara K, Sato C: Ca2+-dependent deimination-induced disassembly of intermediate filaments involves specific modification of the amino-terminal head domain. J Biol Chem. 1989, 264: 18119-18127.PubMed Inagaki M, Takahara H, Nishi Y, Sugawara K, Sato C: Ca2+-dependent deimination-induced disassembly of intermediate filaments involves specific modification of the amino-terminal head domain. J Biol Chem. 1989, 264: 18119-18127.PubMed
5.
go back to reference Takahara H, Tsuchida M, Kusubata M, Akutsu K, Tagami S, Sugawara K: Peptidylarginine deiminase of the mouse. Distribution, properties, and immunocytochemical localization. J Biol Chem. 1989, 264: 13361-13368.PubMed Takahara H, Tsuchida M, Kusubata M, Akutsu K, Tagami S, Sugawara K: Peptidylarginine deiminase of the mouse. Distribution, properties, and immunocytochemical localization. J Biol Chem. 1989, 264: 13361-13368.PubMed
6.
go back to reference Arita K, Hashimoto H, Shimizu T, Nakashima K, Yamada M, Sato M: Structural basis for Ca(2+)-induced activation of human PAD4. Nat Struct Mol Biol. 2004, 11: 777-783. 10.1038/nsmb799.CrossRefPubMed Arita K, Hashimoto H, Shimizu T, Nakashima K, Yamada M, Sato M: Structural basis for Ca(2+)-induced activation of human PAD4. Nat Struct Mol Biol. 2004, 11: 777-783. 10.1038/nsmb799.CrossRefPubMed
7.
go back to reference Chavanas S, Méchin MC, Nachat R, Adoue V, Coudane F, Serre G, Simon M: Peptidylarginine deiminases and deimination in biology and pathology: relevance to skin homeostasis. J Dermatol Sci. 2006, 44: 63-72. 10.1016/j.jdermsci.2006.07.004.CrossRefPubMed Chavanas S, Méchin MC, Nachat R, Adoue V, Coudane F, Serre G, Simon M: Peptidylarginine deiminases and deimination in biology and pathology: relevance to skin homeostasis. J Dermatol Sci. 2006, 44: 63-72. 10.1016/j.jdermsci.2006.07.004.CrossRefPubMed
8.
go back to reference Bicker KL, Thompson PR: The protein arginine deiminases: structure, function, inhibition, and disease. Biopolymers. 2013, 99: 155-163. 10.1002/bip.22127.PubMedCentralCrossRefPubMed Bicker KL, Thompson PR: The protein arginine deiminases: structure, function, inhibition, and disease. Biopolymers. 2013, 99: 155-163. 10.1002/bip.22127.PubMedCentralCrossRefPubMed
9.
go back to reference Chang X, Han J: Expression of peptidylarginine deiminase type 4 (PAD4) in various tumors. Mol Carcinog. 2006, 45: 183-196. 10.1002/mc.20169.CrossRefPubMed Chang X, Han J: Expression of peptidylarginine deiminase type 4 (PAD4) in various tumors. Mol Carcinog. 2006, 45: 183-196. 10.1002/mc.20169.CrossRefPubMed
10.
go back to reference Chang X, Han J, Pang L, Zhao Y, Yang Y, Shen Z: Increased PADI4 expression in blood and tissues of patients with malignant tumors. BMC Cancer. 2009, 9: 40-10.1186/1471-2407-9-40.PubMedCentralCrossRefPubMed Chang X, Han J, Pang L, Zhao Y, Yang Y, Shen Z: Increased PADI4 expression in blood and tissues of patients with malignant tumors. BMC Cancer. 2009, 9: 40-10.1186/1471-2407-9-40.PubMedCentralCrossRefPubMed
11.
go back to reference Baka Z, Barta P, Losonczy G, Krenács T, Pápay J, Szarka E, Sármay G, Babos F, Magyar A, Géher P, Buzás EI, Nagy G: Specific expression of PAD4 and citrullinated proteins in lung cancer is not associated with anti-CCP antibody production. Int Immunol. 2011, 23: 405-414. 10.1093/intimm/dxr026.CrossRefPubMed Baka Z, Barta P, Losonczy G, Krenács T, Pápay J, Szarka E, Sármay G, Babos F, Magyar A, Géher P, Buzás EI, Nagy G: Specific expression of PAD4 and citrullinated proteins in lung cancer is not associated with anti-CCP antibody production. Int Immunol. 2011, 23: 405-414. 10.1093/intimm/dxr026.CrossRefPubMed
12.
go back to reference Chang X, Hou X, Pan J, Fang K, Wang L: Expression of peptidylarginine deiminase type 4 in Ec. Int J Biomed Sci. 2011, 7: 769-781. Chang X, Hou X, Pan J, Fang K, Wang L: Expression of peptidylarginine deiminase type 4 in Ec. Int J Biomed Sci. 2011, 7: 769-781.
13.
go back to reference Cherrington BD, Zhang X, McElwee JL, Morency E, Anguish LJ, Coonrod SA: Potential role for PAD2 in gene regulation in breast cancer cells. PLoS One. 2012, 7: e41242-10.1371/journal.pone.0041242.PubMedCentralCrossRefPubMed Cherrington BD, Zhang X, McElwee JL, Morency E, Anguish LJ, Coonrod SA: Potential role for PAD2 in gene regulation in breast cancer cells. PLoS One. 2012, 7: e41242-10.1371/journal.pone.0041242.PubMedCentralCrossRefPubMed
14.
go back to reference Mohanan S, Cherrington BD, Horibata S, McElwee JL, Thompson PR, Coonrod SA: Potential role of peptidylarginine deiminase enzymes and protein citrullination in cancer pathogenesis. Biochem Res Int. 2012, 2012: 895343-PubMedCentralCrossRefPubMed Mohanan S, Cherrington BD, Horibata S, McElwee JL, Thompson PR, Coonrod SA: Potential role of peptidylarginine deiminase enzymes and protein citrullination in cancer pathogenesis. Biochem Res Int. 2012, 2012: 895343-PubMedCentralCrossRefPubMed
15.
go back to reference Li P, Yao H, Zhang Z, Li M, Luo Y, Thompson PR, Gilmour DS, Wang Y: Regulation of p53 target gene expression by peptidylarginine deiminase. Mol Cell Biol. 2008, 28: 4745-4758. 10.1128/MCB.01747-07.PubMedCentralCrossRefPubMed Li P, Yao H, Zhang Z, Li M, Luo Y, Thompson PR, Gilmour DS, Wang Y: Regulation of p53 target gene expression by peptidylarginine deiminase. Mol Cell Biol. 2008, 28: 4745-4758. 10.1128/MCB.01747-07.PubMedCentralCrossRefPubMed
16.
go back to reference Yao H, Li P, Venters BJ, Zheng S, Thompson PR, Pugh BF, Wang Y: Histone Arg modifications and p53 regulate the expression of OKL38, a mediator of apoptosis. J Biol Chem. 2008, 283: 20060-20068. 10.1074/jbc.M802940200.PubMedCentralCrossRefPubMed Yao H, Li P, Venters BJ, Zheng S, Thompson PR, Pugh BF, Wang Y: Histone Arg modifications and p53 regulate the expression of OKL38, a mediator of apoptosis. J Biol Chem. 2008, 283: 20060-20068. 10.1074/jbc.M802940200.PubMedCentralCrossRefPubMed
17.
go back to reference Li P, Wang D, Yao H, Doret P, Hao G, Shen Q, Qiu H, Zhang X, Wang Y, Chen G, Wang Y: Coordination of PAD4 and HDAC2 in the regulation of p53-target gene expression. Oncogene. 2010, 29: 3153-3162. 10.1038/onc.2010.51.PubMedCentralCrossRefPubMed Li P, Wang D, Yao H, Doret P, Hao G, Shen Q, Qiu H, Zhang X, Wang Y, Chen G, Wang Y: Coordination of PAD4 and HDAC2 in the regulation of p53-target gene expression. Oncogene. 2010, 29: 3153-3162. 10.1038/onc.2010.51.PubMedCentralCrossRefPubMed
18.
go back to reference Tanikawa C, Espinosa M, Suzuki A, Masuda K, Yamamoto K, Tsuchiya E, Ueda K, Daigo Y, Nakamura Y, Matsuda K: Regulation of histone modification and chromatin structure by the p53-PADI4 pathway. Nat Commun. 2012, 3: 676-CrossRefPubMed Tanikawa C, Espinosa M, Suzuki A, Masuda K, Yamamoto K, Tsuchiya E, Ueda K, Daigo Y, Nakamura Y, Matsuda K: Regulation of histone modification and chromatin structure by the p53-PADI4 pathway. Nat Commun. 2012, 3: 676-CrossRefPubMed
19.
go back to reference Guo Q, Bedford MT, Fast W: Discovery of peptidylarginine deiminase-4 substrates by protein array: antagonistic citrullination and methylation of human ribosomal protein S2. Mol Biosyst. 2011, 7: 2286-2295. 10.1039/c1mb05089c.PubMedCentralCrossRefPubMed Guo Q, Bedford MT, Fast W: Discovery of peptidylarginine deiminase-4 substrates by protein array: antagonistic citrullination and methylation of human ribosomal protein S2. Mol Biosyst. 2011, 7: 2286-2295. 10.1039/c1mb05089c.PubMedCentralCrossRefPubMed
21.
go back to reference Chang X, Yamada R, Suzuki A, Kochi Y, Sawada T, Yamamoto K: Citrullination of fibronectin in rheumatoid arthritis synovial tissue. Rheumatology. 2005, 44: 1374-1382. 10.1093/rheumatology/kei023.CrossRefPubMed Chang X, Yamada R, Suzuki A, Kochi Y, Sawada T, Yamamoto K: Citrullination of fibronectin in rheumatoid arthritis synovial tissue. Rheumatology. 2005, 44: 1374-1382. 10.1093/rheumatology/kei023.CrossRefPubMed
22.
go back to reference Chang X, Jian X, Yan X: Expression and citrullination of keratin in synovial tissue of rheumatoid arthritis. Rheumatol Int. 2009, 29: 1337-1342. 10.1007/s00296-009-0863-1.CrossRefPubMed Chang X, Jian X, Yan X: Expression and citrullination of keratin in synovial tissue of rheumatoid arthritis. Rheumatol Int. 2009, 29: 1337-1342. 10.1007/s00296-009-0863-1.CrossRefPubMed
23.
go back to reference Chang X, Yamada R, Sawada T, Suzuki A, Kochi Y, Yamamoto K: The inhibition of antithrombin by peptidylarginine deiminase 4 may contribute to pathogenesis of rheumatoid arthritis. Rheumatology. 2005, 44: 293-298. 10.1093/rheumatology/keh473.CrossRefPubMed Chang X, Yamada R, Sawada T, Suzuki A, Kochi Y, Yamamoto K: The inhibition of antithrombin by peptidylarginine deiminase 4 may contribute to pathogenesis of rheumatoid arthritis. Rheumatology. 2005, 44: 293-298. 10.1093/rheumatology/keh473.CrossRefPubMed
24.
go back to reference Ordóñez A, Yélamos J, Pedersen S, Miñano A, Conesa-Zamora P, Kristensen SR, Stender MT, Thorlacius-Ussing O, Martínez-Martínez I, Vicente V, Corral J: Increased levels of citrullinated antithrombin in plasma of patients with rheumatoid arthritis and colorectal adenocarcinoma determined by a newly developed ELISA using a specific monoclonal antibody. Thromb Haemost. 2010, 104: 1143-1149. 10.1160/TH10-05-0297.CrossRefPubMed Ordóñez A, Yélamos J, Pedersen S, Miñano A, Conesa-Zamora P, Kristensen SR, Stender MT, Thorlacius-Ussing O, Martínez-Martínez I, Vicente V, Corral J: Increased levels of citrullinated antithrombin in plasma of patients with rheumatoid arthritis and colorectal adenocarcinoma determined by a newly developed ELISA using a specific monoclonal antibody. Thromb Haemost. 2010, 104: 1143-1149. 10.1160/TH10-05-0297.CrossRefPubMed
25.
go back to reference Yan X, Yin L, Wang Y, Zhao Y, Chang X: The low binding affinity of ADAMTS4 for citrullinated fibronectin may contribute to the destruction of joint cartilage in rheumatoid arthritis. Clin Exp Rheumatol. 2013, 31: 201-206.PubMed Yan X, Yin L, Wang Y, Zhao Y, Chang X: The low binding affinity of ADAMTS4 for citrullinated fibronectin may contribute to the destruction of joint cartilage in rheumatoid arthritis. Clin Exp Rheumatol. 2013, 31: 201-206.PubMed
26.
go back to reference Zhang Y, Li M, Liu Y, Han N, Zhang K, Xiao T, Cheng S, Gao Y: ENO1 protein levels in the tumor tissues and circulating plasma samples of non-small cell lung cancer patients. Zhongguo Fei Ai Za Zhi. 2010, 13: 1089-1093.PubMed Zhang Y, Li M, Liu Y, Han N, Zhang K, Xiao T, Cheng S, Gao Y: ENO1 protein levels in the tumor tissues and circulating plasma samples of non-small cell lung cancer patients. Zhongguo Fei Ai Za Zhi. 2010, 13: 1089-1093.PubMed
27.
go back to reference He P, Naka T, Serada S, Fujimoto M, Tanaka T, Hashimoto S, Shima Y, Yamadori T, Suzuki H, Hirashima T, Matsui K, Shiono H, Okumura M, Nishida T, Tachibana I, Norioka N, Norioka S, Kawase I: Proteomics-based identification of alpha-enolase as a tumor antigen in non-small lung cancer. Cancer Sci. 2007, 98: 1234-1240. 10.1111/j.1349-7006.2007.00509.x.CrossRefPubMed He P, Naka T, Serada S, Fujimoto M, Tanaka T, Hashimoto S, Shima Y, Yamadori T, Suzuki H, Hirashima T, Matsui K, Shiono H, Okumura M, Nishida T, Tachibana I, Norioka N, Norioka S, Kawase I: Proteomics-based identification of alpha-enolase as a tumor antigen in non-small lung cancer. Cancer Sci. 2007, 98: 1234-1240. 10.1111/j.1349-7006.2007.00509.x.CrossRefPubMed
28.
go back to reference Tsai ST, Chien IH, Shen WH, Kuo YZ, Jin YT, Wong TY, Hsiao JR, Wang HP, Shih NY, Wu LW: ENO1, a potential prognostic head and neck cancer marker, promotes transformation partly via chemokine CCL20 induction. Eur J Cancer. 2010, 46: 1712-1723. 10.1016/j.ejca.2010.03.018.CrossRefPubMed Tsai ST, Chien IH, Shen WH, Kuo YZ, Jin YT, Wong TY, Hsiao JR, Wang HP, Shih NY, Wu LW: ENO1, a potential prognostic head and neck cancer marker, promotes transformation partly via chemokine CCL20 induction. Eur J Cancer. 2010, 46: 1712-1723. 10.1016/j.ejca.2010.03.018.CrossRefPubMed
29.
go back to reference Avni R, Cohen B, Neeman M: Hypoxic stress and cancer: imaging the axis of evil in tumor metastasis. NMR Biomed. 2011, 24: 569-581.PubMedCentralPubMed Avni R, Cohen B, Neeman M: Hypoxic stress and cancer: imaging the axis of evil in tumor metastasis. NMR Biomed. 2011, 24: 569-581.PubMedCentralPubMed
30.
go back to reference Ghosh JC, Siegelin MD, Dohi T, Altieri DC: Heat shock protein 60 regulation of the mitochondrial permeability transition pore in tumor cells. Cancer Res. 2010, 70: 8988-8993. 10.1158/0008-5472.CAN-10-2225.PubMedCentralCrossRefPubMed Ghosh JC, Siegelin MD, Dohi T, Altieri DC: Heat shock protein 60 regulation of the mitochondrial permeability transition pore in tumor cells. Cancer Res. 2010, 70: 8988-8993. 10.1158/0008-5472.CAN-10-2225.PubMedCentralCrossRefPubMed
31.
go back to reference Ghosh JC, Dohi T, Kang BH, Altieri DC: Hsp60 regulation of tumor cell apoptosis. J Biol Chem. 2008, 283: 5188-5194.CrossRefPubMed Ghosh JC, Dohi T, Kang BH, Altieri DC: Hsp60 regulation of tumor cell apoptosis. J Biol Chem. 2008, 283: 5188-5194.CrossRefPubMed
32.
go back to reference Castilla C, Congregado B, Conde JM, Medina R, Torrubia FJ, Japón MA, Sáez C: Immunohistochemical expression of Hsp60 correlates with tumor progression and hormone resistance in prostate cancer. Urology. 2010, 76: 1017-CrossRefPubMed Castilla C, Congregado B, Conde JM, Medina R, Torrubia FJ, Japón MA, Sáez C: Immunohistochemical expression of Hsp60 correlates with tumor progression and hormone resistance in prostate cancer. Urology. 2010, 76: 1017-CrossRefPubMed
33.
go back to reference Desmetz C, Bibeau F, Boissière F, Bellet V, Rouanet P, Maudelonde T, Mangé A, Solassol J: Proteomics-based identification of HSP60 as a tumor-associated antigen in early stage breast cancer and ductal carcinoma in situ. J Proteome Res. 2008, 7: 3830-3837. 10.1021/pr800130d.CrossRefPubMed Desmetz C, Bibeau F, Boissière F, Bellet V, Rouanet P, Maudelonde T, Mangé A, Solassol J: Proteomics-based identification of HSP60 as a tumor-associated antigen in early stage breast cancer and ductal carcinoma in situ. J Proteome Res. 2008, 7: 3830-3837. 10.1021/pr800130d.CrossRefPubMed
34.
go back to reference Chun JN, Choi B, Lee KW, Lee DJ, Kang DH, Lee JY, Song IS, Kim HI, Lee SH, Kim HS, Lee NK, Lee SY, Lee KJ, Kim J, Kang SW: Cytosolic Hsp60 is involved in the NF-kappaB-dependent survival of cancer cells via IKK regulation. PLoS One. 2010, 5: e9422-10.1371/journal.pone.0009422.PubMedCentralCrossRefPubMed Chun JN, Choi B, Lee KW, Lee DJ, Kang DH, Lee JY, Song IS, Kim HI, Lee SH, Kim HS, Lee NK, Lee SY, Lee KJ, Kim J, Kang SW: Cytosolic Hsp60 is involved in the NF-kappaB-dependent survival of cancer cells via IKK regulation. PLoS One. 2010, 5: e9422-10.1371/journal.pone.0009422.PubMedCentralCrossRefPubMed
35.
go back to reference Hall A: The cytoskeleton and cancer. Cancer Metastasis Rev. 2009, 28: 5-14. 10.1007/s10555-008-9166-3.CrossRefPubMed Hall A: The cytoskeleton and cancer. Cancer Metastasis Rev. 2009, 28: 5-14. 10.1007/s10555-008-9166-3.CrossRefPubMed
36.
go back to reference Kelley MJ, Li S, Harpole DH: Genetic analysis of the beta-tubulin gene, TUBB, in non-small-cell lung cancer. J Natl Cancer Inst. 2001, 93: 1886-1888. 10.1093/jnci/93.24.1886.CrossRefPubMed Kelley MJ, Li S, Harpole DH: Genetic analysis of the beta-tubulin gene, TUBB, in non-small-cell lung cancer. J Natl Cancer Inst. 2001, 93: 1886-1888. 10.1093/jnci/93.24.1886.CrossRefPubMed
37.
go back to reference Ohishi Y, Oda Y, Basaki Y, Kobayashi H, Wake N, Kuwano M, Tsuneyoshi M: Expression of beta-tubulin isotypes in human primary ovarian carcinoma. Gynecol Oncol. 2007, 105: 586-592. 10.1016/j.ygyno.2007.01.044.CrossRefPubMed Ohishi Y, Oda Y, Basaki Y, Kobayashi H, Wake N, Kuwano M, Tsuneyoshi M: Expression of beta-tubulin isotypes in human primary ovarian carcinoma. Gynecol Oncol. 2007, 105: 586-592. 10.1016/j.ygyno.2007.01.044.CrossRefPubMed
38.
go back to reference Hadfield JA, Ducki S, Hirst N, McGown AT: Tubulin and microtubules as targets for anticancer drugs. Prog Cell Cycle Res. 2003, 5: 309-325.PubMed Hadfield JA, Ducki S, Hirst N, McGown AT: Tubulin and microtubules as targets for anticancer drugs. Prog Cell Cycle Res. 2003, 5: 309-325.PubMed
39.
go back to reference Walker LC, Harris GC, Holloway AJ, McKenzie GW, Wells JE, Robinson BA, Morris CM: Cytokeratin KRT8/18 expression differentiates distinct subtypes of grade 3 invasive ductal carcinoma of the breast. Cancer Genet Cytogenet. 2007, 178: 94-103. 10.1016/j.cancergencyto.2007.06.002.CrossRefPubMed Walker LC, Harris GC, Holloway AJ, McKenzie GW, Wells JE, Robinson BA, Morris CM: Cytokeratin KRT8/18 expression differentiates distinct subtypes of grade 3 invasive ductal carcinoma of the breast. Cancer Genet Cytogenet. 2007, 178: 94-103. 10.1016/j.cancergencyto.2007.06.002.CrossRefPubMed
40.
go back to reference Schutte B, Henfling M, Kölgen W, Bouman M, Meex S, Leers MP, Nap M, Björklund V, Björklund P, Björklund B, Lane EB, Omary MB, Jörnvall H, Ramaekers FC: Keratin 8/18 breakdown and reorganization during apoptosis. Exp Cell Res. 2004, 297: 11-26. 10.1016/j.yexcr.2004.02.019.CrossRefPubMed Schutte B, Henfling M, Kölgen W, Bouman M, Meex S, Leers MP, Nap M, Björklund V, Björklund P, Björklund B, Lane EB, Omary MB, Jörnvall H, Ramaekers FC: Keratin 8/18 breakdown and reorganization during apoptosis. Exp Cell Res. 2004, 297: 11-26. 10.1016/j.yexcr.2004.02.019.CrossRefPubMed
Metadata
Title
Investigating citrullinated proteins in tumour cell lines
Authors
Zhongmin Jiang
Yazhou Cui
Lin Wang
Yan Zhao
Suhua Yan
Xiaotian Chang
Publication date
01-12-2013
Publisher
BioMed Central
Published in
World Journal of Surgical Oncology / Issue 1/2013
Electronic ISSN: 1477-7819
DOI
https://doi.org/10.1186/1477-7819-11-260

Other articles of this Issue 1/2013

World Journal of Surgical Oncology 1/2013 Go to the issue